Epidemiological Profile of Hemophilia in Baghdad-Iraq

Hemophilia is an inherited bleeding disorder that mainly affects males. Globally, there are about 400 000 people with hemophilia and only 25% of them receive adequate treatment. There is insufficient epidemiological data on hemophilia in Iraq; so, this study was conducted to determine the trend of t...

Full description

Bibliographic Details
Main Authors: Kamal Abdul Razzaq Kadhim MBChB, Faris Hasan Al-Lami MBChB, PhD, FFPH, Kadhim Hussein Baldawi MBChB, MSc
Format: Article
Language:English
Published: SAGE Publishing 2019-05-01
Series:Inquiry: The Journal of Health Care Organization, Provision, and Financing
Online Access:https://doi.org/10.1177/0046958019845280
_version_ 1818419946251616256
author Kamal Abdul Razzaq Kadhim MBChB
Faris Hasan Al-Lami MBChB, PhD, FFPH
Kadhim Hussein Baldawi MBChB, MSc
author_facet Kamal Abdul Razzaq Kadhim MBChB
Faris Hasan Al-Lami MBChB, PhD, FFPH
Kadhim Hussein Baldawi MBChB, MSc
author_sort Kamal Abdul Razzaq Kadhim MBChB
collection DOAJ
description Hemophilia is an inherited bleeding disorder that mainly affects males. Globally, there are about 400 000 people with hemophilia and only 25% of them receive adequate treatment. There is insufficient epidemiological data on hemophilia in Iraq; so, this study was conducted to determine the trend of the prevalence and incidence and to identify certain clinical and epidemiological characteristics of patients with hemophilia in Baghdad, Iraq, 2016. This cross-sectional study was conducted in the 4 hemophilia centers in Baghdad. The data were compiled by reviewing all hemophilia patients’ records and the centers’ registry books between 2007 and 2016. Corresponding population data of Baghdad were obtained from the Ministry of Health. The total number of currently registered patients who are residents of Baghdad was 654. The prevalence of hemophilia increased from 7.2/100 000 males in 2007 to 15.9/100 000 males in 2016. Similarly, the incidence of hemophilia had increased from 8.4/100 000 livebirths in 2007 to 16.3/100 000 livebirths in 2016. Severe hemophilia represented 63.4% of all types. The prevalence of hepatitis C virus (HCV), hepatitis B virus (HBV), and HIV infections were 22.9%, 0.9%, and 0.2%, respectively. Clotting factor inhibitors were positive in 11.6% and target joints were found among 45.1% of patients. About 27% were on prophylactic therapy. Only one death was recorded in 2016. The prevalence and incidence of hemophilia in Baghdad was doubled in 10-year period. The prevalence of different complications was almost close to the rates in the neighboring countries.
first_indexed 2024-12-14T12:46:39Z
format Article
id doaj.art-d83ec10e3f9f4a67b568ef63affc6eb3
institution Directory Open Access Journal
issn 0046-9580
1945-7243
language English
last_indexed 2024-12-14T12:46:39Z
publishDate 2019-05-01
publisher SAGE Publishing
record_format Article
series Inquiry: The Journal of Health Care Organization, Provision, and Financing
spelling doaj.art-d83ec10e3f9f4a67b568ef63affc6eb32022-12-21T23:00:46ZengSAGE PublishingInquiry: The Journal of Health Care Organization, Provision, and Financing0046-95801945-72432019-05-015610.1177/0046958019845280Epidemiological Profile of Hemophilia in Baghdad-IraqKamal Abdul Razzaq Kadhim MBChB0Faris Hasan Al-Lami MBChB, PhD, FFPH1Kadhim Hussein Baldawi MBChB, MSc2Iraq Ministry of Health, Baghdad, IraqUniversity of Baghdad, IraqIraq Ministry of Health, Baghdad, IraqHemophilia is an inherited bleeding disorder that mainly affects males. Globally, there are about 400 000 people with hemophilia and only 25% of them receive adequate treatment. There is insufficient epidemiological data on hemophilia in Iraq; so, this study was conducted to determine the trend of the prevalence and incidence and to identify certain clinical and epidemiological characteristics of patients with hemophilia in Baghdad, Iraq, 2016. This cross-sectional study was conducted in the 4 hemophilia centers in Baghdad. The data were compiled by reviewing all hemophilia patients’ records and the centers’ registry books between 2007 and 2016. Corresponding population data of Baghdad were obtained from the Ministry of Health. The total number of currently registered patients who are residents of Baghdad was 654. The prevalence of hemophilia increased from 7.2/100 000 males in 2007 to 15.9/100 000 males in 2016. Similarly, the incidence of hemophilia had increased from 8.4/100 000 livebirths in 2007 to 16.3/100 000 livebirths in 2016. Severe hemophilia represented 63.4% of all types. The prevalence of hepatitis C virus (HCV), hepatitis B virus (HBV), and HIV infections were 22.9%, 0.9%, and 0.2%, respectively. Clotting factor inhibitors were positive in 11.6% and target joints were found among 45.1% of patients. About 27% were on prophylactic therapy. Only one death was recorded in 2016. The prevalence and incidence of hemophilia in Baghdad was doubled in 10-year period. The prevalence of different complications was almost close to the rates in the neighboring countries.https://doi.org/10.1177/0046958019845280
spellingShingle Kamal Abdul Razzaq Kadhim MBChB
Faris Hasan Al-Lami MBChB, PhD, FFPH
Kadhim Hussein Baldawi MBChB, MSc
Epidemiological Profile of Hemophilia in Baghdad-Iraq
Inquiry: The Journal of Health Care Organization, Provision, and Financing
title Epidemiological Profile of Hemophilia in Baghdad-Iraq
title_full Epidemiological Profile of Hemophilia in Baghdad-Iraq
title_fullStr Epidemiological Profile of Hemophilia in Baghdad-Iraq
title_full_unstemmed Epidemiological Profile of Hemophilia in Baghdad-Iraq
title_short Epidemiological Profile of Hemophilia in Baghdad-Iraq
title_sort epidemiological profile of hemophilia in baghdad iraq
url https://doi.org/10.1177/0046958019845280
work_keys_str_mv AT kamalabdulrazzaqkadhimmbchb epidemiologicalprofileofhemophiliainbaghdadiraq
AT farishasanallamimbchbphdffph epidemiologicalprofileofhemophiliainbaghdadiraq
AT kadhimhusseinbaldawimbchbmsc epidemiologicalprofileofhemophiliainbaghdadiraq